The Future Outlook of Antimalarial Drugs and Recent Work on the Treatment of Malaria
Authors:
- Polrat WilairatanaPWPolrat Wilairatana
- Srivicha KrudsoodSKSrivicha Krudsood
- Sombat TreeprasertsukSTSombat Treeprasertsuk
- Kobsiri ChalermrutKCKobsiri Chalermrut
- Sornchai LooareesuwanSLSornchai Looareesuwan
- 1 July 2002
- journal article
- Published by Elsevier in Archives of Medical Research
- Vol. 33 (4) , 416-421
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Dose‐finding and efficacy study for i.m. artemotil (beta‐arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malariaBritish Journal of Clinical Pharmacology, 2002
- Clinical trial of sequential treatments of moderately severe and severe malaria with dihydroartemisinin suppository followed by mefloquine in Thailand.The American Journal of Tropical Medicine and Hygiene, 2000
- Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in ThailandTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Randomized Dose‐Ranging Study of the Safety and Efficacy of WR 238605 (Tafenoquine) in the Prevention of Relapse ofPlasmodium vivaxMalaria in ThailandThe Journal of Infectious Diseases, 1999
- Malaria: New Developments in Treatment and PreventionAnnual Review of Medicine, 1999
- Artesunate suppositories: an effective treatment for severe falciparum malaria in rural areasPathogens and Global Health, 1997
- Randomised trial of mefloquine-tetracycline and quinine-tetracycline for acute uncomplicated falciparum malariaActa Tropica, 1994
- The mode of action and the mechanism of resistance to antimalarial drugsActa Tropica, 1994
- Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malariaThe Lancet, 1992
- The prevention of antimalarial drug resistancePharmacology & Therapeutics, 1990